Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in mice. EBioMedicine.

Farooq Syed, Olivia Ballew, Chih-Chun Lee, Jyoti Rana, Preethi Krishnan, Angela Castela, Staci A Weaver, Namratha Shivani Chalasani, Sofia F Thomaidou, Stephane Demine, Garrick Chang, Alexandra Coomans de Brachène, Maria Ines Alvelos, Lorella Marselli, Kara Orr, Jamie L Felton, Jing Liu, Piero Marchetti, Arnaud Zaldumbide, Donalyn Scheuner, Decio L Eizirik, Carmella Evans-Molina

Risk of liver-related events in metabolic dysfunction–associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteria

Pennisi Grazia; Enea Marco; Romero-Gomez Manuel; Bugianesi Elisabetta; Wai-Sun Wong Vincent; Fracanzani Anna Ludovica; de Ledinghen Victor; George Jacob; Berzigotti Annalisa; Viganò, Mauro; Sebastiani Giada; Cannella Roberto; Delamarre Adèle; Di Maria Gabriele; Lange Naomi F.; Tulone Adele; Di Marco Vito; Cammà Calogero; Petta Salvatore

IL-33 stimulates the anticancer activities of eosinophils through extracellular vesicle-driven reprogramming of tumor cells

Adriana Rosa Gambardella, Caterina Antonucci, Cristiana Zanetti, Francesco Noto, Sara Andreone, Davide Vacca, Valentina Pellerito, Chiara Sicignano, Giuseppe Parrottino, Valentina Tirelli, Antonella Tinari, Mario Falchi, Adele De Ninno, Luca Businaro, Stefania Loffredo, Gilda Varricchi, Claudio Tripodo, Claudia Afferni, Isabella Parolini, Fabrizio Mattei & Giovanna Schiavoni